Am J Health-Syst Pharm
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Order Full text via Infotrieve
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bjornson, D.
Right arrow Articles by Litman, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bjornson, D.
Right arrow Articles by Litman, T.
American Journal of Hospital Pharmacy, Vol 47, Issue 7, 1541-1546
Copyright © 1990 by American Society of Health-System Pharmacists


Articles

Impact of a drug-use review program intervention on prescribing after publication of a randomized clinical trial

DC Bjornson, TS Rector, CE Daniels, AI Wertheimer, DA Snowdon, and TJ Litman


The effect of a drug-use review (DUR) program intervention on physician prescribing after the results of a randomized clinical trial were published was studied. A Veterans Administration (VA) cooperative study published in June 1986 showed that congestive heart failure (CHF) patients who had hydralazine and isosorbide added to their drug therapy had less mortality than patients given digoxin and diuretics with or without prazosin. Physicians with at least one CHF patient who was receiving the less effective therapy were randomly assigned to intervention and control groups. In September 1986, intervention-group physicians (n = 288) were mailed a letter and questionnaire from the DUR program coordinator, the journal article, and a drug history profile of a CHF patient who might benefit from the information. Control physicians received no mailing. The questionnaire asked whether the physicians already knew about the VA study, intended to alter their prescribing, and could identify factors that would affect their decision. Two thirds of intervention-group physicians were already aware of the VA study. One third indicated that they intended to alter drug therapy based on the study results; factors significantly associated with the intent to adopt a change were physician training and experience, comments by peers, new drug availability, and the size of the reduction in mortality. During four months after the intervention, only 5 physicians in the two groups switched their patients to both hydralazine and isosorbide (full change); 23 switched them to at least one of the drugs or discontinued prazosin (partial change). There was no significant difference in the number of full or partial changes between groups.(ABSTRACT TRUNCATED AT 250 WORDS)
 



This article has been cited by other articles:


Home page
CMAJHome page
C. R. Dormuth, M. Maclure, K. Bassett, C. Jauca, C. Whiteside, and J. M. Wright
Effect of periodic letters on evidence-based drug therapy on prescribing behaviour: a randomized trial
Can. Med. Assoc. J., October 26, 2004; 171(9): 1057 - 1061.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
C. I Coleman, P. Reddy, N M. Laster-Bradley, S. Dorval, B. Munagala, and C M. White
Effect of Practitioner Education on Adherence to Asthma Treatment Guidelines
Ann. Pharmacother., July 1, 2003; 37(7): 956 - 961.
[Abstract] [Full Text] [PDF]


Home page
American Journal of Medical QualityHome page
J. Studnicki, R. Remmel, R. Campbell, and D. C. Werner
The Impact of Legislatively Imposed Practice Guidelines on Cesarean Section Rates: The Florida Experience
American Journal of Medical Quality, March 1, 1997; 12(1): 62 - 68.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by the American Society of Health-System Pharmacists.